Discovery of novel drug-like antitubercular hits targeting the MEP pathway enzyme DXPS by strategic application of ligand-based virtual screening
Open Access
- 8 August 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 13 (36) , 10686-10698
Abstract
In the present manuscript, we describe how we successfully used ligand-based virtual screening (LBVS) to identify two small-molecule, drug-like hit classes with excellent ADMET profiles against the difficult to address microbial enzyme 1-deoxy-D-xylulose-5-phosphate synthase (DXPS). In the fight against antimicrobial resistance (AMR), it has become increasingly important to address novel targets such as DXPS, the first enzyme of the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway, which affords the universal isoprenoid precursors. This pathway is absent in humans but essential for pathogens such as Mycobacterium tuberculosis, making it a rich source of drug targets for the development of novel anti-infectives. Standard computer-aided drug-design tools, frequently applied in other areas of drug development, often fail for targets with large, hydrophilic binding sites such as DXPS. Therefore, we introduce the concept of pseudo-inhibitors, combining the benefits of pseudo-ligands (defining a pharmacophore) and pseudo-receptors (defining anchor points in the binding site), for providing the basis to perform a LBVS against M. tuberculosis DXPS. Starting from a diverse set of reference ligands showing weak inhibition of the orthologue from Deinococcus radiodurans DXPS, we identified three structurally unrelated classes with promising in vitro (against M. tuberculosis DXPS) and whole-cell activity including extensively drug-resistant strains of M. tuberculosis. The hits were validated to be specific inhibitors of DXPS and to have a unique mechanism of inhibition. Furthermore, two of the hits have a balanced profile in terms of metabolic and plasma stability and display a low frequency of resistance development, making them ideal starting points for hit-to-lead optimization of antibiotics with an unprecedented mode of action.Keywords
All Related Versions
Funding Information
- H2020 European Research Council (ERC Starting grant: 757913)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (731.015.414)
This publication has 59 references indexed in Scilit:
- Hit Identification and Optimization in Virtual Screening: Practical Recommendations Based on a Critical Literature AnalysisJournal of Medicinal Chemistry, 2013
- 1-Deoxy-d-xylulose 5-Phosphate Synthase Catalyzes a Novel Random Sequential MechanismJournal of Biological Chemistry, 2011
- Chemical Rescue of Malaria Parasites Lacking an Apicoplast Defines Organelle Function in Blood-Stage Plasmodium falciparumPLOS Biology, 2011
- Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparumScientific Reports, 2011
- The herbicide ketoclomazone inhibits 1-deoxy-D-xylulose 5-phosphate synthase in the 2-C-methyl-D-erythritol 4-phosphate pathway and shows antibacterial activity against Haemophilus influenzaeThe Journal of Antibiotics, 2010
- Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screeningNature Reviews Drug Discovery, 2008
- Screening in a spirit haunted worldDrug Discovery Today, 2006
- Better antibiotics through chemistryNature Reviews Drug Discovery, 2004
- Properties and inhibition of the first two enzymes of the non-mevalonate pathway of isoprenoid biosynthesisBiochemical Society Transactions, 2000
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973